Abstract:Successively predicting whether mild cognitive impairment patients will progress to Alzheimer's disease is of significant clinical relevance. This ability may provide information that can be leveraged by emerging intervention approaches and thus mitigate some of the negative effects of the disease. Neuroimaging biomarkers have gained some attention in recent years and may be useful in predicting the conversion of mild cognitive impairment to Alzheimer's disease. We implemented a novel multi-modal approach that allowed us to evaluate the potential of different imaging modalities, both alone and in different degrees of combinations, in predicting the conversion to Alzheimer's disease of mild cognitive impairment patients. We applied this approach to the imaging data from the Alzheimer's Disease Neuroimaging Initiative that is a multi-modal imaging dataset comprised of MRI, Fluorodeoxyglucose PET, Florbetapir PET and diffusion tensor imaging. We included a total of 480 mild cognitive impairment patients that were split into two groups: converted and stable. Imaging data were segmented into atlas-based regions of interest, from which relevant features were extracted for the different imaging modalities and used to construct machine-learning models to classify mild cognitive impairment patients into converted or stable, using each of the different imaging modalities independently. The models were then combined, using a simple weight fusion ensemble strategy, to evaluate the complementarity of different imaging modalities and their contribution to the prediction accuracy of the models. The single-modality findings revealed that the model, utilizing features extracted from Florbetapir PET, demonstrated the highest performance with a balanced accuracy of 83.51%. Concerning multi-modality models, not all combinations enhanced mild cognitive impairment conversion prediction. Notably, the combination of MRI with Fluorodeoxyglucose PET emerged as the most promising, exhibiting an overall improvement in predictive capabilities, achieving a balanced accuracy of 78.43%. This indicates synergy and complementarity between the two imaging modalities in predicting mild cognitive impairment conversion. These findings suggest that β-amyloid accumulation provides robust predictive capabilities, while the combination of multiple imaging modalities has the potential to surpass certain single-modality approaches. Exploring modality-specific biomarkers, we identified the brainstem as a sensitive biomarker for both MRI and Fluorodeoxyglucose PET modalities, implicating its involvement in early Alzheimer's pathology. Notably, the corpus callosum and adjacent cortical regions emerged as potential biomarkers, warranting further study into their role in the early stages of Alzheimer's disease.

Prognostic model for predicting Alzheimer's disease conversion using functional connectome manifolds

Prediction of conversion from amnestic mild cognitive impairment to alzheimer’s disease based on brain structural connectome

Prediction of Mild Cognitive Impairment Conversion Using a Combination of Independent Component Analysis and the Cox Model

Risk factors and predictive models in the progression from MCI to Alzheimer's disease

Prediction of Conversion from Mild Cognitive Impairment to Alzheimer's Disease Using MRI and Structural Network Features.

A multimodal machine learning model for predicting dementia conversion in Alzheimer's disease

Risk Prediction of Alzheimer's Disease Conversion in Mild Cognitive Impaired Population Based on Brain Age Estimation

A Multipredictor Model to Predict the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease by Using a Predictive Nomogram

A prediction model of dementia conversion for mild cognitive impairment by combining plasma pTau181 and structural imaging features

Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer’s disease created by integrative analysis of multi-omics data

Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer's Disease.

Dynamic Individual Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Joint Modeling

Multimodal ensemble model for Alzheimer's disease conversion prediction from Early Mild Cognitive Impairment subjects

A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment

Identification Of Conversion From Mild Cognitive Impairment To Alzheimer'S Disease Using Multivariate Predictors

Predicting conversion from MCI to AD by integration of rs-fMRI and clinical information using 3D-convolutional neural network

Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI

Clinical and Neuroimaging Predictors of Alzheimer's Dementia Conversion in Patients with Mild Cognitive Impairment Using Amyloid Positron Emission Tomography by Quantitative Analysis over 2 Years

P4‐172: Disruption of Intrinsic Functional Connectivity Within the Left Temporal Lobe is Linked to Cognition and Increased Total Tau Level in CSF in MCI Patients Who Will Progress to Alzheimer's Disease

Predicting conversion from mild cognitive impairment to Alzheimer's disease: a multimodal approach

Innovative Multivariable Model Combining MRI Radiomics and Plasma Indexes Predicts Alzheimer's Disease Conversion: Evidence from a 2-Cohort Longitudinal Study